May & Baker Nigeria Plc. operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares May & Baker Nigeria Plc. with three other
pharmaceutical manufacturers in Africa:
Unite de Fabrication de Medicaments SA
sales of 87.09 million Dinar [US$30.71 million]
Societe Adwya SA
(108.18 million Dinar [US$38.15 million]
of which 59%
was Pharmacy), and
Ste Tunisienne Des Industries Pharmaceutique SA
based in Tunisia
(31.06 million Dinar [US$10.95 million]
May & Baker Nigeria Plc. reported sales of 8.55 billion Naira (US$27.88 million)
December of 2018.
decrease of 8.6%
versus 2017, when the company's sales were 9.35 billion Naira.